Peer-reviewed journal articles (24)
21.
Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M. M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006). Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 103(9), 3232-3237. doi:10.1073/pnas.050847610323.
Doumont, G., Martoriati, A., Beekman, C., Bogaerts, S., Mee, P. J., Bureau, F., Colombo, E., Alcalay, M., Bellefroid, E., Marchesi, F., Scanziani, E., Pelicci, P. G., & Marine, J.-C. (2005). G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv. EMBO journal, 24(17), 3093-3103. doi:10.1038/sj.emboj.760076924.
Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P. G., & Marine, J.-C. (2005). dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene, 24(8), 1461-1466. doi:10.1038/sj.onc.1208256 Papers published in national and international conferences or symposium proceedings (1)
1.
Lavis, P., Pingitore, J., Doumont, G., Gabaret, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Huaux, F., Decaestecker, C., Salmon, I., Cardozo, A. K., Goldman, S., & Bondue, B. (2023). Fibroblast Activation Protein Inhibitor, a Promising Radiotracer inFibrogenesis. American journal of respiratory and critical care medicine,(207), A4704. doi:https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A4704 Theses and master's dissertations (2)